OSTEORAPTOR CURVED 2.3 mm Suture Anchor ULTRABRAID COBRAID Suture, Black; Part Number: 72203291 ...
FDA Device Recall #Z-2227-2013 — Class II — August 6, 2013
Recall Summary
| Recall Number | Z-2227-2013 |
| Classification | Class II — Moderate risk |
| Date Initiated | August 6, 2013 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Smith & Nephew, Inc. Endoscopy Division |
| Location | Andover, MA |
| Product Type | Devices |
| Quantity | 4946 US |
Product Description
OSTEORAPTOR CURVED 2.3 mm Suture Anchor ULTRABRAID COBRAID Suture, Black; Part Number: 72203291 Biodegradable suture anchor
Reason for Recall
Pinholes detected in a small number of primary pouches that may constitute a breach of the sterile barrier.
Distribution Pattern
Worldwide Distribution - USA (nationwide) Canada, Europe: Austria, Belgium, Cyprus, Czech Republic, Denmark, Germany, Greece, Finland, France, Italy, Ireland, Luxembourg, Netherlands, Norway, Poland, Portugal, Russia, Slovenia, Spain, Sweden, Switzerland, Turkey, Ukraine and United Kingdom, Asia-pacific: Australia, China, Dubai, Hong Kong, India, Japan, Malaysia, New Zealand, Philippines, Sri Lanka, Singapore, South Korea, Taiwan, Thailand, Argentina, Bermuda, Brazil, Chile, Colombia, Costa Rica, Israel, Mexico, Puerto Rico, South Africa, and Venezuela.
Lot / Code Information
50366964 50366974 50366982 50366987 50366991 50370758 50370941 50370943 50371293 50376477 50387447 50392962 50394696 50397924 50400302 50400308 50408067 50414256 50415787 50417207 50419579 50425118 50428815 50429654 50431732 50435075 50435211 50444669 50445035 50445761 50445877 50450950 50458418 50458435
Other Recalls from Smith & Nephew, Inc. Endoscopy Division
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-2045-2014 | Class II | SUTUREFIX Ultra Anchor XL with one (#2) Ultrabr... | Jun 2, 2014 |
| Z-2049-2014 | Class II | SUTUREFIX Ultra S Double Loaded Suture Product... | Jun 2, 2014 |
| Z-2046-2014 | Class II | SUTUREFIX Ultra Anchor XL with one (#2) Ultrabr... | Jun 2, 2014 |
| Z-2047-2014 | Class II | SUTUREFIX Ultra S with 1 #2 Ultrabraid (blue) ... | Jun 2, 2014 |
| Z-2048-2014 | Class II | SUTUREFIX Ultra S with 1 #2 Ultrabraid Suture (... | Jun 2, 2014 |
Frequently Asked Questions
Sterility recalls for medical devices vary in severity. If you have already had a procedure using a potentially non-sterile device, contact your healthcare provider immediately — you may need monitoring for signs of infection. Symptoms to watch for include fever, redness or swelling at the surgical site, unusual pain, or discharge. For devices that have not yet been used, they should be quarantined and returned to the manufacturer per the recall notice. Non-sterile implants can cause serious infections; early detection and treatment are critical.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.